Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Total Assignments:
2
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10161279
|
Filing Dt:
|
06/03/2002
|
|
Publication #:
|
|
Pub Dt:
|
02/05/2004
| | | | |
|
Inventors:
|
John H. Griffin, J. Kevin Judice, Burton G. Christensen, Thomas E. Jenkins
|
|
Title:
|
Novel therapeutic agents that modulate enzymatic processes
|
|
|
Assignment:
1
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 901 GATEWAY BOULEVARD |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
|
|
| THERAVANCE, INC. |
| DAVID BOONE, ESQ. |
| 901 GATEWAY BOULEARD |
| SOUTH SAN FRANCISCO, CA 94080 |
|
|
|
Assignment:
2
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 901 GATEWAY BOULEVARD |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
|
|
| JEFFREY A. HAGENAH |
| PATENT DEPARTMENT |
| THERAVANCE BIOPHARMA US, INC. |
| 901 GATEWAY BOULEVARD |
| SOUTH SAN FRANCISCO, CALIFORNIA 94080 |
|
|
Search Results as of:
05/07/2024 09:54 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
